Remarkable Breast Cancer Trial Destroys Tumors In Just 11 Days


Breast cancer is the most common cancer for women in both the developed and less developed world. Currently, early detection is the best way to increase survival rates in patients, and there are various treatments available designed to neutralize tumors. Despite considerable medical advances, however, over half a million women died in 2011 from breast cancer.

New research presented at the European Breast Cancer Conference in Amsterdam has revealed that a pair of drugs are able to eliminate some types of breast cancers in just 11 days. This surprising finding, which came out of a Cancer Research UK-funded trial, means that some women afflicted with breast cancer may never need to undergo chemotherapy.

Remarkable Breast Cancer Trial Destroys Tumors In Just 11 Days

The trial aimed to investigate the effects of Herceptin and Lapatinib, two drugs commonly used during one type of breast cancer treatment, following tumor-removal surgery and conventional chemotherapy. They both work by targeting a protein known as HER2, one that drives the growth of some types of breast cancers, including some particularly aggressive variants. | NEXT – In this instance, 257 women with HER2-positive breast cancer were given the drug combination after being diagnosed, before surgery was due to take place…

>> NEXT : 257 women with HER2-positive breast cancer were given the drug combination

Pages: 1 2